Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced ...
Roche has got in on the B7-H3 action, agreeing to $570 million in near-term payments to existing partner MediLink Therapeutics for an antibody-drug conjugate targeting the immune checkpoint protein.
An antibody-drug conjugate (ADC) that GSK licensed from China's Hansoh Pharma in a $1.7 billion deal last year has been given breakthrough status by the FDA. The coveted designation for GSK5764227 ...
The content on this page was created using generative artificial intelligence powered only by Cars.com articles and edited by Cars.com’s Editorial team for accuracy. The Toyota Highlander debuted in ...
The content on this page was created using generative artificial intelligence powered only by Cars.com articles and edited by Cars.com’s Editorial team for accuracy. One of the longest-running and ...
Biological models are experimental systems that recreate aspects of human tissue function or disease. For example, certain tumour cell lines may serve as cancer models, and transgenic mice that ...
Cancer models are naturally existing or artificially induced systems that share features with human cancers. Experimental systems for studying human cancer include cell lines and organisms such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results